English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The title compound, [Fe(C 14 H 14 N 3 O 2 )Cl 2 ]·[ZnCl 2 (C 14 H 15 N 3 O 2 )], is formulated as [Fe III (bpg)Cl 2 ][Zn II Cl 2 (bpgH)], where bpg is the tetra­dentate ligand  N , N -bis­(2-pyridylmeth­yl)glycine. The structure contains one crystallographically distinct complex with Fe III  and Zn II  atoms present in a 50:50 ratio in a single-atom site. The non-coordinated O atoms of the carboxyl groups of bpg meet across crystallographic inversion centres, forming O—H⋯O hydrogen bonds that include only one H atom per two complexes, consistent with the 1:1 disorder of Fe III  and Zn II .

acta crystallographica. section e

[N,N-Bis(2-pyridylmethyl)glycinato-κ4N,N′,N′′,O]dichloridoiron(III)–[N,N-bis(2-pyridylmethyl)glycine-κ4N,N′,N′′,O]dichloridozinc(II) (1/1)